跳至主要内容
临床试验/NCT01019889
NCT01019889已完成3 期

Effect of Socheongryong-tang and Yeongyopaedok-san in Upper Respiratory Tract Infection

Korea Health Industry Development Institute0 个研究点目标入组 480 人开始时间: 2008年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
480
主要终点
Changes of score daily measured by WURSS-K before, during and after treatment

研究概览

简要总结

The purpose of this study is to determine whether Socheongryong-tang (SCRT) and Yeongyopaedok-san (YPS) are effective in the treatment of upper respiratory tract infection.

详细描述

Upper respiratory tract infections (URTIs) are the most prevalent disease of human beings, it incur a significant health burden on populations in terms of human suffering and economic losses. Usually, antibiotic therapy is not helpful since most infections are virally induced. Over 200 serologically different viral types are responsible for human URTIs, so that preventions of URTIs including vaccination are impassable. SCRT and YPS are widely used to treat the respiratory disease. The objective of this study is to determine the efficacy of SCRT and YPS in symptomatic relief of patients with URTIs.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 18~60 years old
  • Clinical diagnosis of common cold
  • Occurring no longer than 48 hours before enrollment
  • Presented with runny nose, sore throat, plugged nose, scratchy throat, cough, hoarseness, headache, muscle ache (runny nose, sore throat and at least 1 of others or 1 of runny nose, sore throat and at least 3 of others)

排除标准

  • Allergic rhinitis, asthma, COPD, sinusitis (2 and more recurrence per year), septal deviation, anatomical otitis media, exudative pharyngitis
  • Received antihistamines, NSAIDs, corticosteroids, antibiotics, decongestants
  • Hepatic cancer, liver cirrhosis, renal failure, congestive heart failure
  • Pregnant or lactation

研究组 & 干预措施

Placebo

Experimental

Placebo (encapsulated starch + lactose)

干预措施: Placebo (Drug)

SCRT(Socheongryong-tang )

Experimental

encapsulated Socheongryong-tang extract

干预措施: SCRT (Drug)

YPS (Yeongyopaedok-san)

Experimental

Encapsulated Yeongyopaedok-san extract

干预措施: YPS (Drug)

结局指标

主要结局

Changes of score daily measured by WURSS-K before, during and after treatment

时间窗: daily (7 days)

次要结局

  • Time of symptom disappearance(daily)
  • Changes of score daily measured by WURSS-K before, during and after treatment in pattern identification(daily (7days))

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Yang Chun Park

Professor

Korea Health Industry Development Institute

相似试验